KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 81 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,401,000 | 0.0% | 153,449 | 0.0% | 0.62% | +3.7% |
| Q4 2018 | $1,401,000 | -19.7% | 153,449 | +50.4% | 0.60% | +0.2% |
| Q3 2018 | $1,744,000 | +2135.9% | 102,006 | +774.7% | 0.60% | +1516.2% |
| Q2 2016 | $78,000 | -25.0% | 11,662 | 0.0% | 0.04% | -26.0% |
| Q1 2016 | $104,000 | -32.9% | 11,662 | 0.0% | 0.05% | -32.4% |
| Q4 2015 | $155,000 | +26.0% | 11,662 | 0.0% | 0.07% | +19.4% |
| Q3 2015 | $123,000 | -61.2% | 11,662 | 0.0% | 0.06% | -56.9% |
| Q2 2015 | $317,000 | -11.2% | 11,662 | 0.0% | 0.14% | -11.7% |
| Q1 2015 | $357,000 | +149.7% | 11,662 | +205.4% | 0.16% | +143.3% |
| Q4 2014 | $143,000 | +7.5% | 3,819 | 0.0% | 0.07% | – |
| Q3 2014 | $133,000 | -25.3% | 3,819 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $178,000 | – | 3,819 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |